No neurodevelopmental benefit of cerebral oximetry in the first randomised trial (SafeBoosC II) in preterm infants during the first days of life.
Acta Paediatr
; 108(2): 275-281, 2019 02.
Article
in En
| MEDLINE
| ID: mdl-29908039
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Hypoxia, Brain
/
Neurodevelopmental Disorders
Type of study:
Clinical_trials
Limits:
Child, preschool
/
Female
/
Humans
/
Male
/
Newborn
Language:
En
Journal:
Acta Paediatr
Year:
2019
Document type:
Article
Affiliation country:
Denmark
Country of publication:
Norway